Status:
TERMINATED
The Effect of PTH(1-84) or Alendronate on Reduction of Back Pain in Postmenopausal Women With an Osteoporosis Related Vertebral Fracture(s) (FP-005-IM)
Lead Sponsor:
Nycomed
Conditions:
Back Pain
Eligibility:
FEMALE
50+ years
Phase:
PHASE4
Brief Summary
The primary objective of this trial is to show that PTH(1-84) is superior to alendronate in reducing back pain intensity over a 24-week treatment period in postmenopausal women with an osteoporosis re...
Eligibility Criteria
Inclusion
- Postmenopausal women with a T-score ≤ -1.5 SD and at least one osteoporosis related vertebral fracture. Chronic back pain.
Exclusion
- Previous/current treatment and medical history.
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT00713258
Start Date
April 1 2008
End Date
September 1 2010
Last Update
May 8 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nycomed
Roskilde, Denmark, 4000